Ensysce Biosciences Reports Third Quarter 2024 Financial Results
ENSC Stock | USD 0.49 0.01 2.00% |
About 57% of Ensysce Biosciences' investor base is looking to short. The analysis of the overall investor sentiment regarding Ensysce Biosciences suggests that many traders are alarmed. The current market sentiment, together with Ensysce Biosciences' historical and current headlines, can help investors time the market. In addition, many technical investors use Ensysce Biosciences stock news signals to limit their universe of possible portfolio assets.
Ensysce |
Awarded 14 Million Multi-Year NIH Grant and Initiated Second Clinical Trial for Breakthrough Therapy PF614-MPARSubmitted Pivotal PF614 Phase 3 Protocol to the FDA for Review SAN DIEGO, CA ACCESSWIR
Read at accesswire.com
Ensysce Biosciences Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Ensysce Biosciences can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Ensysce Biosciences Fundamental Analysis
We analyze Ensysce Biosciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ensysce Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ensysce Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Outstanding
Shares Outstanding Comparative Analysis
Ensysce Biosciences is currently under evaluation in shares outstanding category among its peers. Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Ensysce Biosciences Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Ensysce Biosciences stock to make a market-neutral strategy. Peer analysis of Ensysce Biosciences could also be used in its relative valuation, which is a method of valuing Ensysce Biosciences by comparing valuation metrics with similar companies.
Peers
Ensysce Biosciences Related Equities
BDRX | Biodexa Pharmaceticals | 14.00 | ||||
PHIO | Phio Pharmaceuticals | 3.03 | ||||
ATNF | 180 Life | 1.83 | ||||
QNRX | Quoin Pharmaceuticals | 1.69 | ||||
ZURA | Zura Bio | 1.67 | ||||
REVB | Revelation Biosciences | 1.33 | ||||
ALLR | Allarity Therapeutics | 0.90 | ||||
SONN | Sonnet Biotherapeutics | 2.28 | ||||
CDIO | Cardio Diagnostics | 3.23 | ||||
VRAX | Virax Biolabs | 4.83 | ||||
KPRX | Kiora Pharmaceuticals | 8.68 |
Complementary Tools for Ensysce Stock analysis
When running Ensysce Biosciences' price analysis, check to measure Ensysce Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ensysce Biosciences is operating at the current time. Most of Ensysce Biosciences' value examination focuses on studying past and present price action to predict the probability of Ensysce Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ensysce Biosciences' price. Additionally, you may evaluate how the addition of Ensysce Biosciences to your portfolios can decrease your overall portfolio volatility.
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
FinTech Suite Use AI to screen and filter profitable investment opportunities |